Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20
What Is The Expected Total Market Size Of The Molluscum Contagiosum (MC) Treatment Industry By The Forecast Year 2029?
The molluscum contagiosum (mc) treatment market has shown strong expansion over recent years. It is anticipated to grow from $2.93 billion in 2024 to $3.1 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 5.9%. This historical growth can be attributed to several factors: increased public awareness concerning skin infections and their available treatments, a rise in cases affecting children, elevated healthcare spending, an increasing number of individuals with compromised immune systems, and greater funding from both private and government organizations.
The molluscum contagiosum (mc) treatment market size is anticipated to experience substantial growth in the upcoming years, expanding to $3.86 billion by 2029 with a compound annual growth rate (CAGR) of 5.7%. This projected growth during the forecast period is attributed to an increasing preference for non-invasive treatments, a rising prevalence of skin diseases, growing demand for healthcare services, the increasing prevalence of chronic diseases, and the improved availability of advanced treatment options. Significant trends expected in this period include a shift toward cosmetic treatment approaches, the development of new topical delivery systems, a move towards at-home treatments, advancements in cryotherapy methods, and an increased focus on pediatric treatment options.
Unlock Your Free Sample Report for Exclusive Market Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21225&type=smp
Which Factors And Drivers Are Influencing The Molluscum Contagiosum (MC) Treatment Market In 2025?
The molluscum contagiosum treatment market is projected to grow due to the increasing demand for minimally invasive treatments. These medical procedures involve minimal bodily harm, typically through small or no incisions. The demand for minimally invasive treatments stems from their ability to shorten recovery times, lessen surgical risks, and improve patient results when compared to traditional procedures. For molluscum contagiosum treatment, minimally invasive techniques such as cryotherapy and laser therapy are employed for effective removal, faster recovery, and reduced scarring. Such treatments also require fewer visits and are well-suited for managing the often widespread lesions associated with molluscum contagiosum. For instance, in February 2024, data from the American Academy of Facial Plastic and Reconstructive Surgery, a US-based non-profit organization, indicated that in 2023, minimally invasive procedures accounted for 83% of all medical procedures, totaling 35 million procedures in 2023, while traditional surgical procedures constituted the remaining 17%. Therefore, the rising demand for minimally invasive treatments is driving the expansion of the molluscum contagiosum treatment market.
How Is The Molluscum Contagiosum (MC) Treatment Market Segmented?
The molluscum contagiosum (mc) treatmentmarket covered in this report is segmented –
1) By Type: Molluscum Contagiosum Virus (MCV) -1; Molluscum Contagiosum Virus (MCV) -2; Molluscum Contagiosum Virus (MCV) -3; Molluscum Contagiosum Virus (MCV) -4
2) By Treatment Type: Topical Therapy; Immune-Modulators And Procedural Treatments
3) By Route Of Administration: Topical; Oral
4) By End User: Hospitals; Dermatology Clinics; Homecare Settings; Other End Users
What Long-Term Trends Will Shape The Future Growth Of The Molluscum Contagiosum (MC) Treatment Industry?
Leading companies within the molluscum contagiosum (MC) treatment market are concentrating on developing innovative products, such as topical gels, to boost effectiveness, improve patient adherence, and offer non-invasive treatment methods. A topical gel is defined as a semi-solid preparation applied onto the skin or mucous membranes for localized therapeutic action or treatment. For instance, in April 2024, Ligand Pharmaceuticals Incorporated, a US-based biopharmaceutical firm, introduced Pelthos Therapeutics to market Zelsuvmi (brazier) topical gel, 10.3%. This product represents the initial Food and Drug Administration-approved at-home treatment for molluscum contagiosum in adults and children over one-year-old. This gel works by releasing nitric oxide, which is formulated to interfere with viral replication, thereby facilitating the resolution of lesions. Zelsuvmi provides a non-invasive and painless alternative to conventional in-office procedures like cryotherapy or curettage, establishing itself as a practical and convenient choice for patients aged one year and older.
Who Are The Key Multinational Companies Dominating The Molluscum Contagiosum (MC) Treatment Market?
Major companies operating in the molluscum contagiosum (MC) treatment market are Verrica Pharmaceuticals, Novan Inc., Veloce BioPharma LLC, Gurina Foundation, Competition Deep Dive, Azafaros, Polaryx Therapeutics, Abbott Medtronic, Merck & Co., Inc., Pfizer Inc., Siemens Healthcare GmbH, Novartis, Ligand Pharmaceuticals Incorporated, Aclaris Therapeutics Inc., Verrica Pharmaceuticals Inc., Nielsen BioSciences Inc., MedCara Pharmaceuticals LLC, Gurina Foundation, Veloce BioPharma LLC, Labo ACM
Download The Full Report For Exclusive Market Findings:
Which Region Shows The Highest Potential For Future Expansion In The Molluscum Contagiosum (MC) Treatment Market?
North America was the largest region in the molluscum contagiosum (MC) treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the molluscum contagiosum (MC) treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Version Of The Molluscum Contagiosum (MC) Treatment Market Report:
https://www.thebusinessresearchcompany.com/customise?id=21225&type=smp
Browse Through More Reports Similar to the Global Molluscum Contagiosum (MC) Treatment Market 2025, By The Business Research Company
Pseudomonas Aeruginosa Infection Treatment Global Market Report 2025
Nicotine Addiction Treatment Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/nicotine-addiction-treatment-global-market-report
Gastric Volvulus Treatment Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/gastric-volvulus-treatment-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model